[被诊断为sarcopenic肥胖症可能会给严重肥胖症带来额外的临床影响]
M D Ballesteros Pomar1, E González Arnáiz1
1Endocrinología y Nutrición, Complejo Asistencial Universitario de León, León, España.
Semergen
|January 9, 2026
概括
肥胖症在减肥手术候选人中很常见,并且与健康状况不佳有关. 诊断它突出了这些患者的临床风险增加和身体功能恶化.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 肥胖医学 肥胖医学
背景情况:
- 肥胖症 (SO) 结合了多余的脂肪和肌肉损失,增加了健康风险.
- SO与较高的心血管和代谢问题,残疾和死亡率有关.
研究的目的:
- 为了确定诊断SO是否会影响严重肥胖患者接受减肥手术的临床决策.
主要方法:
- 这是一项针对124名年龄在18-60岁的严重肥胖患者 (BMI>40或35-40并发症) 的前性研究.
- 评估身体组成 (DXA),肌肉力量 (抓地力) 和体力表现 (定时启动).
- 根据ESPEN/EASO标准诊断的SO.
主要成果:
- 22.6%的患者患有SO,体重,BMI和腰围都较高.
- 在SO患者中,高血压,2型糖尿病和高甘油血症的发病率增加.
- SO与较差的体力表现和较高的跌倒风险有关,但与生活质量无关.
结论:
- 肥胖症在减肥手术候选人中很普遍.
- SO与更糟糕的心脏代谢和功能特征有关.
- 诊断SO可以识别具有更高临床风险的患者.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Barrett Esophagus-II: Clinical Manifestations and Management
777
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
777


